Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 19 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-13.31 Insider Own28.46% Shs Outstand1.04M Perf Week-4.69%
Market Cap7.39M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float0.75M Perf Month4.25%
Income-15.96M PEG- EPS next Q- Inst Own1.19% Short Float1.16% Perf Quarter1.57%
Sales0.00M P/S- EPS this Y- Inst Trans- Short Ratio1.68 Perf Half Y-21.21%
Book/sh22.46 P/B0.32 EPS next Y- ROA-43.50% Short Interest0.01M Perf Year-14.85%
Cash/sh15.70 P/C0.45 EPS next 5Y- ROE-47.07% 52W Range5.25 - 17.40 Perf YTD-3.92%
Dividend Est.- P/FCF- EPS past 5Y- ROI-68.22% 52W High-59.14% Beta0.84
Dividend TTM- Quick Ratio6.34 Sales past 5Y-33.33% Gross Margin- 52W Low35.33% ATR (14)0.37
Dividend Ex-Date- Current Ratio6.34 EPS Y/Y TTM-20.79% Oper. Margin0.00% RSI (14)43.96 Volatility0.68% 3.78%
Employees8 Debt/Eq0.00 Sales Y/Y TTM-100.00% Profit Margin- Recom1.00 Target Price40.00
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q-23.32% Payout- Rel Volume0.10 Prev Close7.15
Sales Surprise- EPS Surprise- Sales Q/Q-100.00% Earnings- Avg Volume5.17K Price7.11
SMA20-5.63% SMA50-2.02% SMA200-15.95% Trades Volume541 Change-0.56%
Apr-15-24 11:00AM
Feb-13-24 07:59AM
Jan-08-24 07:59AM
Jan-02-24 08:35AM
Dec-28-23 05:00PM
05:19PM Loading…
Dec-19-23 05:19PM
Dec-13-23 09:03AM
Dec-11-23 11:18AM
Nov-29-23 04:27PM
Nov-09-23 07:59AM
Sep-14-23 08:30AM
Sep-07-23 04:14PM
Aug-01-23 07:59AM
06:00AM Loading…
Jul-31-23 06:00AM
Jul-20-23 08:43AM
Jul-13-23 09:14AM
Jun-30-23 09:28AM
Jun-29-23 02:50PM
Jun-06-23 04:30PM
Jun-05-23 09:00AM
Jun-01-23 07:57AM
May-14-23 08:13AM
May-03-23 08:26AM
Mar-02-23 08:00AM
Feb-23-23 08:00AM
Feb-16-23 07:30AM
08:00AM Loading…
Jan-18-23 08:00AM
Dec-14-22 05:18PM
Dec-12-22 07:00AM
Dec-07-22 04:00PM
Dec-06-22 08:00AM
Nov-28-22 07:05PM
Nov-22-22 04:00PM
Oct-27-22 09:50AM
Oct-17-22 08:00AM
Oct-14-22 09:48AM
Oct-13-22 04:00PM
Oct-12-22 08:00AM
Oct-10-22 09:39AM
Oct-03-22 06:03PM
Sep-28-22 09:00AM
Sep-20-22 08:00AM
Sep-15-22 08:00AM
Sep-12-22 11:53AM
Sep-09-22 10:32AM
Sep-06-22 09:30AM
Aug-24-22 08:00AM
Aug-18-22 08:00AM
Aug-11-22 08:00AM
Aug-05-22 09:00AM
Aug-02-22 07:00AM
Jul-14-22 08:00AM
Jun-23-22 09:00AM
Jun-22-22 08:00AM
Apr-14-22 04:15PM
Apr-05-22 03:57PM
Mar-30-22 04:15PM
Mar-08-22 08:00AM
Feb-24-22 08:00AM
Feb-09-22 08:00AM
Feb-03-22 08:00AM
Jan-26-22 08:00AM
Dec-23-21 11:35AM
Dec-21-21 08:00AM
Dec-01-21 08:00AM
Nov-29-21 05:45PM
Nov-24-21 08:52AM
Nov-23-21 11:39AM
Nov-17-21 08:00AM
Nov-11-21 08:00AM
Nov-09-21 08:00AM
Oct-27-21 11:40AM
Oct-18-21 01:37PM
Oct-14-21 09:13AM
Oct-11-21 10:08AM
Oct-05-21 08:37AM
Oct-04-21 08:00AM
Sep-29-21 04:30PM
Sep-20-21 12:51PM
Pasithea Therapeutics Corp. is a biotechnology company focuses on the research and discovery of new and treatments for psychiatric and neurological disorders. The company was founded by Yassine Bendiabdallah and Steinman Lawrence J in May, 2020 and is headquartered in Miami Beach, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
STEINMAN LAWRENCEDirectorJun 02 '23Buy0.4330,00012,9301,327,174Jun 06 09:00 PM